Pfizer Inc. (PFE) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Core Insights - The conference features Albert Bourla, CEO of Pfizer, discussing the current external environment affecting the pharmaceutical industry, particularly in relation to drug pricing policies [3][4]. Group 1: Industry Environment - There is significant anxiety among investors regarding the impact of the drug pricing MFN (Most Favored Nation) executive order, which has led to depressed multiples across the pharmaceutical sector [4]. - The industry is anticipating a range of outcomes from the recent executive order, with implications for both the near term and the long term [4]. Group 2: Company Position - Albert Bourla's unique perspective as the Chair of the Pharma lobbying group provides insights into the ongoing discussions with the administration and the potential effects on the pharmaceutical sector [3]. - The conference serves as a platform for Pfizer to address investor concerns and outline the company's position amidst regulatory changes [3].